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Although the tremendous catalytic power of enzymes is widely recognized, their 
exact mechanisms of action are still a source of debate. In order to elucidate the 
origin of their power, it is necessary to look at individual residues and atoms, 
and establish their contribution to ligand binding, activation, and reaction. Given 
the present limitations of experimental techniques, only computational tools 
allow for such detailed analysis. During my PhD studies I have applied a variety 
of computational methods, reviewed in Chapter 2, to the study of two enzymes: 
DfrB dihydrofolate reductase (DHFR) and methyltetrahydrofolate: 
corrinoid/iron-sulfur protein methyltransferase (MeTr). 
The DfrB enzyme has intrigued microbiologists since it was discovered thirty 
years ago, because of its simple structure, enzymatic inefficiency, and its 
insensitivity to trimethoprim. This bacterial enzyme shows neither structural nor 
sequence similarity with its chromosomal counterpart, despite both catalysing 
the reduction of dihydrofolate (DHF) using NADPH as a cofactor. As numerous 
attempts to obtain experimental structures of an enzyme ternary complex have 
been unsuccessful, I combined docking studies and molecular dynamics 
simulations to produce a reliable model of the reactive DfrB•DHF•NADPH 
complex. These results, combined with published empirical data, showed that 
multiple binding modes of the ligands are possible within DfrB. 
Comprehensive sequence and structural analysis provided further insight into the 
DfrB family. The presence of the dfrB genes within integrons and their level of 
sequence conservation suggest that they are old structures that had been 
diverging well before the introduction of trimethoprim. Each monomer of the 
tetrameric active enzyme presents an SH3-fold domain; this is a eukaryotic 
auxiliary domain never found before as the sole domain of a protein, let alone as 
the catalytic one. Overall, DfrB DHFR seems to be a poorly adapted catalyst, a 
‘minimalistic’ enzyme that promotes the reaction by facilitating the approach of 
the ligands rather than by using specific catalytic residues. 
 viii
MeTr initiates the Wood-Ljungdahl pathway of anaerobic CO2 fixation. It 
catalyses the transfer of the N5-methyl group from N5-methyltetrahydrofolate 
(CH3THF) to the cobalt centre of a corrinoid/iron-sulfur protein. For the reaction 
to occur, the N5 position of CH3THF is expected to be activated by protonation. 
As experimental studies have led to conflicting suggestions, computational 
approaches were used to address the activation mechanism. 
Initially, I tested the accuracy of quantum mechanical (QM) methods to predict 
protonation positions and pKas of pterin, folate, and their analogues. Then, 
different protonation states of CH3THF and active-site aspartic residues were 
analysed. Fragment QM calculations suggested that the pKa of N5 in CH3THF is 
likely to increase upon protein binding. Further, ONIOM calculations which 
accounted for the complete protein structure indicated that active-site aspartic 
residues are likely to be protonated before the ligand. Finally, solvation and 
binding free energies of several protonated forms of CH3THF were compared 
using the thermodynamic integration approach. Taken together, these 
preliminary results suggest that further work with particular emphasis on the 
protonation state of active-site aspartic residues is needed in order to elucidate 
the protonation and activation mechanism of CH3THF within MeTr. 
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